Fifth Third Bancorp’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $217K | Buy |
9,617
+8,810
| +1,092% | +$196K | ﹤0.01% | 2490 |
|
|
2025
Q4 | $20.9K | Buy |
807
+6
| +0.7% | +$143 | ﹤0.01% | 1877 |
|
|
2025
Q3 | $20.6K | Sell |
801
-288
| -26% | -$7.07K | ﹤0.01% | 1877 |
|
|
2025
Q2 | $26K | Sell |
1,089
-514
| -32% | -$13K | ﹤0.01% | 1677 |
|
|
2025
Q1 | $39.8K | Buy |
1,603
+48
| +3% | +$1.15K | ﹤0.01% | 1501 |
|
|
2024
Q4 | $29.3K | Sell |
1,555
-69
| -4% | -$1.21K | ﹤0.01% | 1601 |
|
|
2024
Q3 | $24.4K | Buy |
1,624
+1,354
| +501% | +$23.1K | ﹤0.01% | 1711 |
|
|
2024
Q2 | $7.72K | Sell |
270
-121
| -31% | -$3.44K | ﹤0.01% | 2004 |
|
|
2024
Q1 | $11.4K | Buy |
391
+190
| +95% | +$5.84K | ﹤0.01% | 1830 |
|
|
2023
Q4 | $6.78K | Buy |
201
+80
| +66% | +$2.34K | ﹤0.01% | 2090 |
|
|
2023
Q3 | $3.71K | Sell |
121
-612
| -83% | -$22.1K | ﹤0.01% | 2253 |
|
|
2023
Q2 | $29.4K | Buy |
733
+253
| +53% | +$10.5K | ﹤0.01% | 1581 |
|
|
2023
Q1 | $19.6K | Buy |
480
+276
| +135% | +$11K | ﹤0.01% | 1834 |
|
|
2022
Q4 | $7.88K | Sell |
204
-39
| -16% | -$1.9K | ﹤0.01% | 2050 |
|
|
2022
Q3 | $13K | Sell |
243
-69
| -22% | -$3.84K | ﹤0.01% | 1839 |
|
|
2022
Q2 | $18K | Sell |
312
-15
| -5% | -$983 | ﹤0.01% | 1778 |
|
|
2022
Q1 | $25K | Buy |
327
+31
| +10% | +$2.07K | ﹤0.01% | 1730 |
|
|
2021
Q4 | $18K | Buy |
296
+21
| +8% | +$1.16K | ﹤0.01% | 1897 |
|
|
2021
Q3 | $15K | Buy |
275
+14
| +5% | +$807 | ﹤0.01% | 1883 |
|
|
2021
Q2 | $16K | Sell |
261
-49
| -16% | -$3.1K | ﹤0.01% | 1869 |
|
|
2021
Q1 | $22K | Buy |
310
+120
| +63% | +$8.57K | ﹤0.01% | 1745 |
|
|
2020
Q4 | $11K | Buy |
190
+155
| +443% | +$9.08K | ﹤0.01% | 1900 |
|
|
2020
Q3 | $2K | Buy |
+35
| New | +$2.03K | ﹤0.01% | 2068 |
|
|
2018
Q3 | – | Sell |
-400
| Closed | -$13K | – | 2284 |
|
|
2018
Q2 | $13K | Hold |
400
| – | – | ﹤0.01% | 1799 |
|
|
2018
Q1 | $12K | Hold |
400
| – | – | ﹤0.01% | 1843 |
|
|
2017
Q4 | $18K | Sell |
400
-1,366
| -77% | -$54.1K | ﹤0.01% | 1645 |
|
|
2017
Q3 | $66K | Sell |
1,766
-96
| -5% | -$3.86K | ﹤0.01% | 1206 |
|
|
2017
Q2 | $89K | Buy |
1,862
+39
| +2% | +$1.81K | ﹤0.01% | 1107 |
|
|
2017
Q1 | $83K | Sell |
1,823
-62
| -3% | -$2.68K | ﹤0.01% | 1143 |
|
|
2016
Q4 | $61K | Sell |
1,885
-1,448
| -43% | -$48.3K | ﹤0.01% | 1259 |
|
|
2016
Q3 | $114K | Buy |
3,333
+2,036
| +157% | +$79.8K | ﹤0.01% | 1067 |
|
|
2016
Q2 | $44K | Buy |
1,297
+381
| +42% | +$18.7K | ﹤0.01% | 1339 |
|
|
2016
Q1 | $49K | Buy |
+916
| New | +$53.6K | ﹤0.01% | 1345 |
|
|
2015
Q3 | – | Sell |
-200
| Closed | -$14K | – | 2976 |
|
|
2015
Q2 | $14K | Buy |
+200
| New | +$15.8K | ﹤0.01% | 1948 |
|
Other funds holding PCRX
DPCM
VPM
VCM
